ExecPay

Daniel Yerace

Overview202320222021

Overview

Daniel Yerace received an average of $308K in total compensation, including $283K in salary, at Coeptis Therapeutics Holdings from 2021 to 2023.

Source: SEC filings on November 14, 2024 and November 17, 2023.
Yerace's 2023 pay

Related executives

We found four more executives who work or worked at Coeptis Therapeutics Holdings.

David Mehalick

Coeptis Therapeutics Holdings

Chief Executive Officer

3

Colleen Delaney

Coeptis Therapeutics Holdings

Chief Financial Officer

1

Brian Cogley

Coeptis Therapeutics Holdings

Chief Financial Officer

1

Christine Sheehy

Coeptis Therapeutics Holdings

Chief Financial Officer

3

News

You may also like

Coeptis Therapeutics Holdings